Protocol for the management of acute severe ulcerative colitis in children

Size: px
Start display at page:

Download "Protocol for the management of acute severe ulcerative colitis in children"

Transcription

1 Protocol for the management of acute severe ulcerative colitis in children Introduction: Paediatric UC is severe and more extensive than adult onset UC with 6-8% presenting as pancolitis (1,2) Within five years from diagnosis a significantly higher percentage of patients with childhood onset UC are admitted to emergency units for acute severe colitis, compared to adult onset disease (1,3,4) More children fail intravenous steroids during an acute severe episode (,6) Consequently, this translates into higher colectomy rates in children compared to adult UC populations. It is therefore important to promptly diagnose, initiate treatment and monitor progress during an acute UC flare up. Purpose To deliver standardised/evidenced based practice for all patients admitted with severe Ulcerative Colitis in keeping with current guidelines and IBD standards. These guidelines are intended to assist management of acute severe UC in first hours of presentation. Subsequent management needs to be individualised depending on the clinical improvement and not covered in this document 9. Criteria for Inclusion This protocol apply to those patients who meet the following criteria Patient that have confirmed diagnosis of UC Patient suspected to have a severe flare by Truelove & Witts (7) Classification Score. Six bloody stools associated with one or more further activity within the severe category. Activity Mild Moderate Severe No Bloody Stools per day <4 4-6 >6 Temp Afebrile Intermediate >37.8 Heart Rate Normal Intermediate >9 Haemoglobin (g/dl) > <1. ESR (mm/h) <2 2-3 >3 Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

2 Assessment In addition to usual clinical assessment of an acutely unwell child, it is important to look for following points History Frequency of stooling, stool consistency, blood in stools, nocturnal stools, weight loss, abdominal pain, limitation of activity to calculate Paediatric Ulcerative Colitis Activity Index (PUCAI) which is only specific for ulcerative colitis and not Crohn s disease 8. Check doses of current medications and patient compliance Examination Look for vital signs tachycardia, anaemia, jaundice, dehydration. Abdominal tenderness (Toxic megacolon) Investigations 1. Send stool mc/s (2 samples) and stool for Cl Diff, Faecal calprotectin 2. Blood tests (FBC, Biochemistry including LFTs, CRP, amylase, Alpha 1 acid glycoprotein/esr). Consider sending Azathioprine metabolites (6TGN/6MMPN) if poor compliance is suspected 3. Request abdominal x ray (AXR) to look for toxic megacolon. Repeat AXR should be dictated by the initial AXR and condition Toxic megacolon - Defined as >.cms diameter transverse colon or > 9cms caecum. If present on admission, an urgent surgical referral must be made and commenced on IV antibiotics (cefuroxime and metronidazole) hours of intensive medical therapy may be considered provided patient is sufficiently stable, but a failure to respond by 48 hours, or development of further dilatation during medical therapy mandates consideration of colectomy. Management 1. Calculate PUCAI score (see table 1) and monitor daily to monitor progress. 2. Start methyl prednisolone 1-1. mg per kilogram (max 6 mg) in 2 divided doses. 3. Consider IV antibiotics (as above) if febrile/ infection suspected or likely to need colectomy. 4. Monitor daily PUCAI score. Consider IV fluids if clinically dehydrated. 6. Consider surgical review if AXR suggestive of toxic megacolon 7. Discuss with Paediatric Gastroenterology Consultant on service at Leicester Royal Infirmary (LRI) at earliest opportunity via switchboard. 8. Consider transfer to LRI if clinically indicated. Please note this protocol is only intended for patients with acute severe UC and not for those who have mild to moderate disease. Please discuss with senior colleagues for advice. Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

3 Table 1: PAEDIATRIC ULCERATIVE COLITIS INDEX (PUCAI) Name/DOB: Date: (1) Abdominal pain No pain Pain can be ignored Pain cannot be ignored (2) Rectal bleeding None Small amount in <% stools Small amount with most stools Large amount (>% stool) (3) Stool consistency of most stools Formed Partially formed Completely unformed (4) Number of stools per 24h >8 () Nocturnal stools (any episode causing wakening) No Yes (6) Activity level No limitation of activity Occasional limitation of activity Points Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

4 Severe restricted activity SUM OF PUCAI (-8) Figure 2: Treatment algorithm for acute severe UC (8) Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

5 Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

6 References: 1. Lev-Tzion R, Turner D. Is pediatric IBD treatment different than in adults? Minerva Gastroenterol Dietol 212;8: Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 28;13: Turner D, Walsh CM, Benchimol EI, Mann EH, Thomas KE, Chow C, et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut 28;7: Dinesen LC, Walsh AJ, Protic MN, Heap G, Cummings F, Warren BF, et al. The pattern and outcome of acute severe colitis J Crohns Colitis 21;4: Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 27;: Turner D, Griffiths AM. Acute severe ulcerative colitis in children: a systematic review. Inflamm Bowel Dis 211;17: Truelove S C, Witts L. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ. 19;2: D Turner et al, Am J Gastroenterol. 211 Apr;16(4): Epub 211 Jan Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines. JPGN Volume, Number 3, September 212 Title: Protocol for the management of acute severe ulcerative colitis in children Last reviewed: July 21

Algorithm for managing severe ulcerative colitis

Algorithm for managing severe ulcerative colitis Tropical Gastroenterology 2014;Suppl:S40 44 Algorithm for managing severe ulcerative colitis Vineet Ahuja 1, Ajay Kumar 2, Rakesh Kochhar 3 ABSTRACT Dept of Gastroenterology, 1 All India Institute of Medical

More information

Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients

Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients Tamás Molnár 1, Klaudia Farkas 1, Tibor Nyári 2, Zoltán Szepes 1, Ferenc Nagy 1,

More information

Evaluation of treatment effect in UC and CD (children)

Evaluation of treatment effect in UC and CD (children) Evaluation of treatment effect in UC and CD (children) Dr Nick Croft Digestive Diseases, Centre for Immunobiology, Blizard Institute & Barts Health NHS Trust Blizard Institute Disclosures Dr Nick Croft

More information

Guideline Ulcerative colitis: management

Guideline Ulcerative colitis: management NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline Ulcerative colitis: management Draft for consultation, December 0 This guideline covers the care and treatment of adults, children and young

More information

Achieving Success in Ulcerative Colitis: the Role of Infliximab

Achieving Success in Ulcerative Colitis: the Role of Infliximab Achieving Success in Ulcerative Colitis: the Role of Infliximab Dr Gill Watermeyer IBD clinic Groote Schuur Hospital 17 th August 2012 Inflammatory Bowel Disease Crohn s disease and ulcerative colitis

More information

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency SD, male 40 yrs. old. (680718M467.) -2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine -June 2008: Recurrence of rectal blood loss and urgency Total colonoscopy: ulcerative rectitis,

More information

Management of the Hospitalized IBD Patient. Drew DuPont MD

Management of the Hospitalized IBD Patient. Drew DuPont MD Management of the Hospitalized IBD Patient Drew DuPont MD Ulcerative Colitis: Indications for Admission Severe ulcerative colitis Frequent loose bloody stools ( 6 per day) Severe cramps Systemic toxicity:

More information

Predicting outcome in severe ulcerative colitis

Predicting outcome in severe ulcerative colitis Gut 1996; 38: 95-91 Predicting outcome in severe ulcerative colitis 95 S P L Travis, J M Farrant, C Ricketts, D J Nolan, N M Mortensen, M G W Kettlewell, D P Jewell Gastroenterology Unit S P L Travis J

More information

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital Aims To understand the aetiology of IBD To understand the impact that

More information

Diarrhoea on the AMU. Dr Chris Roseveare

Diarrhoea on the AMU. Dr Chris Roseveare Diarrhoea on the AMU Dr Chris Roseveare The Society for Acute Medicine, Spring Meeting, Radisson Blu Hotel, Dublin 3-4 May 2012 Acute diarrhoea in developed countries adult populations Mainly a primary

More information

Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary

Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary Nutrition as primary therapy in IBD Dr Clare Donnellan Leeds General Infirmary Case GB 34 year old female Diagnosed with Crohn s in 2002? Extent Offered steroids or surgery Declined both GB Represented

More information

Infliximab (Remicade) for paediatric ulcerative colitis - second line

Infliximab (Remicade) for paediatric ulcerative colitis - second line Infliximab (Remicade) for paediatric ulcerative colitis - second line September 2011 This technology summary is based on information available at the time of research and a limited literature search. It

More information

Treatment of Pediatric IBD: What is Different?

Treatment of Pediatric IBD: What is Different? Treatment of Pediatric IBD: What is Different? January 13, 2017 Michael Kappelman MD, MPH University of North Carolina at Chapel Hill Overview Is Pediatric IBD the same disease? Treatment considerations

More information

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS Target Audience: Physicians, Physician Assistants, Nurse Practitioners and Nurses impacted by the protocol. Scope/Patient Population: All adult

More information

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children Stephanie Jones, D.O. Surgical Fellow March 21, 2011 Ulcerative Colitis Spectrum of inflammatory bowel

More information

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS Target Audience: Physicians, Physician Assistants, Nurse Practitioners and Nurses impacted by the protocol. Scope/Patient Population: All adult

More information

Anti-TNF and cyclosporine are identical choices for severe ulcerative colitis refractory to steroid therapy CON Peter Laszlo LAKATOS Semmelweis

Anti-TNF and cyclosporine are identical choices for severe ulcerative colitis refractory to steroid therapy CON Peter Laszlo LAKATOS Semmelweis Anti-TNF and cyclosporine are identical choices for severe ulcerative colitis refractory to steroid therapy CON Peter Laszlo LAKATOS Semmelweis University, 1st Department of Medicine Budapest June 13-15,

More information

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) CROHN S DISEASE Definitions Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) Recurrence: The reappearance of lesions after surgical resection Endoscopic remission:

More information

What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff

What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff Case: Kelly age 19 Admitted via medical intake to local hospital with D&V for 10 days. Ate take-away

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Implementation of disease and safety predictors during disease management in UC

Implementation of disease and safety predictors during disease management in UC Implementation of disease and safety predictors during disease management in UC DR ARIELLA SHITRIT DIGESTIVE DISEASES INSTITUTE SHAARE ZEDEK MEDICAL CENTER JERUSALEM Case presentation A 52 year old male

More information

Which is the Safest Strategy to Treat Moderate to Severe IBD?

Which is the Safest Strategy to Treat Moderate to Severe IBD? Which is the Safest Strategy to Treat Moderate to Severe IBD? David G. Binion, M.D. Co-Director, Inflammatory Bowel Disease Center Director, Translational Inflammatory Bowel Disease Research Visiting Professor

More information

Qualification opinion

Qualification opinion 20 January 2016 EMA/CHMP/SAWP/801872/2015 Committee for Medicinal Products for Human Use (CHMP) Draft agreed by scientific advice working party 01 June 2015 Adopted by CHMP for release for consultation

More information

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS SURGICAL MANAGEMENT OF ULCERATIVE COLITIS Cary B. Aarons, MD Associate Professor of Surgery Division of Colon & Rectal Surgery University of Pennsylvania AGENDA Background Diagnosis/Work-up Medical Management

More information

Trust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over)

Trust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over) Trust Guideline for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis (*ie aged 16 years and over) abc A guideline recommended for use In: Gastroenterology/Medical

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis

Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis The Harvard community has made this article openly available. Please share

More information

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease Measure #270: Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

Clinical Course of Infliximab Treatment in Korean Pediatric Ulcerative Colitis Patients: A Single Center Experience

Clinical Course of Infliximab Treatment in Korean Pediatric Ulcerative Colitis Patients: A Single Center Experience pissn: 2234-8646 eissn: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.1.31 Pediatric Gastroenterology, Hepatology & Nutrition 2014 March 17(1):31-36 Original Article PGHN Clinical Course of Infliximab

More information

Diarrhoea for the Acute Physician

Diarrhoea for the Acute Physician Diarrhoea for the Acute Physician STEPHEN INNS GASTROENTEROLOGIST AND PHYSICIAN HUTT VALLEY DHB August 2013 Outline Case History 1 Initial assessment of acute diarrhoea Management of fulminant UC Management

More information

A Case of Inflammatory Bowel Disease

A Case of Inflammatory Bowel Disease A Case of Inflammatory Bowel Disease Dr Barrie Rathbone www.le.ac.uk 26 year old Polish woman Admitted as emergency under surgeons RUQ and RIF pain Abdominal pain had occurred intermittently for a few

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Ulcerative colitis: the management of ulcerative colitis Quality standard title: Ulcerative

More information

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 South East London Area Prescribing Committee: Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 Developed by: South East London IBD Pathway Development Group Approved: February

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD Disclosure Statement NKC: No relevant conflicts to disclose. DTR: No relevant

More information

Latest Treatment Updates for Ulcerative Colitis: Evolving Treatment Goals

Latest Treatment Updates for Ulcerative Colitis: Evolving Treatment Goals Latest Treatment Updates for Ulcerative Colitis: Evolving Treatment Goals Stephen Hanauer, MD Professor of Medicine Medical Director, Digestive Disease Center Northwestern Medicine Chicago, Illinois Speaker

More information

Current management options and recent advances in IBD

Current management options and recent advances in IBD n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory

More information

Mucosal healing: does it really matter?

Mucosal healing: does it really matter? Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE 1. Medical Condition INFLAMMATORY BOWEL DISEASE (IBD) specifically includes Crohn s disease (CD) and ulcerative colitis (UC) but also includes IBD unclassified (IBDu), seen in about 10% of cases. These

More information

Optimizing the effectiveness of anti-tnf therapy in paediatric IBD

Optimizing the effectiveness of anti-tnf therapy in paediatric IBD Optimizing the effectiveness of anti-tnf therapy in paediatric IBD Anne Griffiths MD, FRCPC Co-Lead, Inflammatory Bowel Disease Center Northbridge Chair in IBD Hospital for Sick Children, Professor of

More information

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D. The Spectrum of IBD Inflammatory Bowel Disease Fernando Vega, M.D. Epidemiology CD and UC together 1:400 UC Prevalence 1:500 UC Incidence 6-12K/annum CD Prevalence 1:1000 CD Incidence 3-6K/annum Symptoms

More information

Clinical Study Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis

Clinical Study Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis Hindawi Publishing Corporation ISRN Gastroenterology Volume 2013, Article ID 179024, 5 pages http://dx.doi.org/10.1155/2013/179024 Clinical Study Fecal Calprotectin and Clinical Disease Activity in Pediatric

More information

Health supervision and prevention of complications in the child with IBD. Athos Bousvaros MD MPH

Health supervision and prevention of complications in the child with IBD. Athos Bousvaros MD MPH Health supervision and prevention of complications in the child with IBD Athos Bousvaros MD MPH 1 NASPGHAN IBD Health Supervision Working Group Paul Rufo Chair William Faubion Co-chair Pushpa Sathya Nutrition

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Acute Colitis Protocol Dr Seamus J Murphy Gastroenterology Acute Date Uploaded: 01/06/18 Review Date June 2021 Clinical Guideline

More information

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND Fabrizio Parente Gastrointestinal Unit, A.Manzoni Hospital, Lecco & L.Sacco School of Medicine,University of Milan - Italy

More information

Paediatric Gastroenterology Clinical Network. Management of Inflammatory Bowel Disease in Children and Adolescents in New Zealand

Paediatric Gastroenterology Clinical Network. Management of Inflammatory Bowel Disease in Children and Adolescents in New Zealand Paediatric Gastroenterology Clinical Network Management of Inflammatory Bowel Disease in Children and Adolescents in New Zealand A Clinical Guideline Prepared by: Dr Andrew Day on behalf of the Paediatric

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s

Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s Hospital GI inflammation IBD Group QIMR Berghofer Medical

More information

LRI Children s Hospital

LRI Children s Hospital LRI Children s Hospital Management of Henoch Schönlein Purpura (HSP) in children Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: July 2017 Version: V 3

More information

Medical Therapy for Pediatric IBD: Efficacy and Safety

Medical Therapy for Pediatric IBD: Efficacy and Safety Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: fecal_calprotectin_test 8/2009 11/2017 11/2018 11/2017 Description of Procedure or Service Fecal calprotectin

More information

Biologics in IBD. Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College

Biologics in IBD. Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College Biologics in IBD Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College Case 30 year old man diagnosed with ulcerative proctitis diagnosed in 2003 Had been maintained

More information

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003 Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two

More information

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic

More information

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS ALL YOU NEED TO KNOW ABOUT ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS THIS FACTSHEET IS ABOUT ULCERATIVE COLITIS. Ulcerative colitis (UC) is a disease of the rectum

More information

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS ALL YOU NEED TO KNOW ABOUT ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS THIS FACTSHEET IS ABOUT ULCERATIVE COLITIS. Ulcerative colitis (UC) is a disease of the rectum

More information

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill The York Faecal Calprotectin Care Pathway for use in primary care James Turvill NICE guidance: dg11 Faecal calprotectin (FC) testing as an option in adults with recent onset of lower gastrointestinal symptoms

More information

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Endpoints Overview Hospitalization Surgery Colorectal cancer

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

Indications for use of Infliximab

Indications for use of Infliximab Indications for use of Infliximab Moscow, June 10 th 2006 Prof. Dr. Dr. Gerhard Rogler Klinik und Poliklinik für Innere Medizin I Universität Regensburg Case report 1989: Diagnosis of Crohn s disease of

More information

Irritable Bowel Syndrome vs Inflammatory Bowel Disease

Irritable Bowel Syndrome vs Inflammatory Bowel Disease Irritable Bowel Syndrome vs Inflammatory Bowel Disease Lana Bistritz MD FRCPC Royal Alexandra Hospital Faculty/Presenter Disclosure Faculty: Lana Bistritz Relationships with financial sponsors: Grants/Research

More information

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management Journal of Crohn's and Colitis, 2017, 769 784 doi:10.1093/ecco-jcc/jjx009 Advance Access publication January 28, 2017 ECCO Guideline/Consensus Paper ECCO Guideline/Consensus Paper Third European Evidence-based

More information

Αναφορές εκβάσεων από τους ασθενείς (Patient Reported Outcomes): Μπορούν να αναβαθμίσουν τον τρόπο παρακολούθησης της νόσου; Γιώργος Μπάμιας

Αναφορές εκβάσεων από τους ασθενείς (Patient Reported Outcomes): Μπορούν να αναβαθμίσουν τον τρόπο παρακολούθησης της νόσου; Γιώργος Μπάμιας Αναφορές εκβάσεων από τους ασθενείς (Patient Reported Outcomes): Μπορούν να αναβαθμίσουν τον τρόπο παρακολούθησης της νόσου; Γιώργος Μπάμιας Σύγκρουση συμφερόντων Γιώργος Μπάμιας τιμητικές αμοιβές απο

More information

Positioning Biologics in Ulcerative Colitis

Positioning Biologics in Ulcerative Colitis Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, MS Acting Chief, Gastrointestinal Unit Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Sequential Therapies

More information

Diagnosing and Managing IBS in IBD Patients. September 2012

Diagnosing and Managing IBS in IBD Patients. September 2012 Diagnosing and Managing IBS in IBD Patients September 2012 Professor David S Sanders Consultant Gastroenterologist Royal Hallamshire Hospital & University of Sheffield Patient Comes to see you with GI

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

SWL Drug Pathway Ulcerative Colitis Version 3 (Oct 2018) (based on NICE ulcerative colitis commissioning algorithm - with local adaptation)

SWL Drug Pathway Ulcerative Colitis Version 3 (Oct 2018) (based on NICE ulcerative colitis commissioning algorithm - with local adaptation) Adult with active ulcerative colitis Does the adult have moderately to severely active ulcerative colitis managed in outpatients with no need for hospitalisation/surgery? Moderately to severely active

More information

fever a persistent unexplained change in bowel habit in somebody over 50 years of age a family history of bowel or ovarian cancer.

fever a persistent unexplained change in bowel habit in somebody over 50 years of age a family history of bowel or ovarian cancer. If you have had these symptoms for some time, if they come and go but never completely go away, then go and see your doctor. In practice, IBS is a diagnosis of exclusion. There is no test or marker that

More information

Use of extrapolation in small clinical trials:

Use of extrapolation in small clinical trials: Use of extrapolation in small clinical trials: Infliximab for pediatric ulcerative colitis Jessica J. Lee, MD, MMSc Medical Officer Division of Gastroenterology and Inborn Errors Products CDER/ FDA 1 Learning

More information

Objectives RECENT ADVANCES IN FECAL MICROBIOTA TRANSFORMATION. TRANSPLANT in Inflammatory Bowel Disease

Objectives RECENT ADVANCES IN FECAL MICROBIOTA TRANSFORMATION. TRANSPLANT in Inflammatory Bowel Disease RECENT ADVANCES IN FECAL MICROBIOTA TRANSFORMATION TRANSPLANT in Inflammatory Bowel Disease David Suskind M.D. Professor of Pediatrics Division of Gastroenterology University of Washington Seattle Children

More information

Genetic Susceptibility. Objectives. What Causes IBD? Inflammatory Bowel Disease

Genetic Susceptibility. Objectives. What Causes IBD? Inflammatory Bowel Disease 4:45 5:30 pm IBD in Pediatrics SPEAKER Jennifer Strople, MD Presenter Disclosure Information The following relationships exist related to this presentation: Jennifer Strople, MD: Speakers Bureau for AbbVie

More information

Ulcerative Colitis: State of the Art 2006

Ulcerative Colitis: State of the Art 2006 Ulcerative Colitis: State of the Art David T. Rubin, MD Assistant Professor of Medicine Inflammatory Bowel Disease Center University of Chicago Improving Management of Ulcerative Colitis (UC) Better classification/diagnostic

More information

Controversies in IBD: Resolving clinical dilemmas using Cochrane reviews

Controversies in IBD: Resolving clinical dilemmas using Cochrane reviews Controversies in IBD: Resolving clinical dilemmas using Cochrane reviews DR. NILESH CHANDE COORDINATING EDITOR, IBD REVIEW GROUP; UNIVERSITY OF WESTERN ONTARIO, LONDON, ON CANADA An international organisation

More information

Diagnostic techniques for surveillance of dysplasia

Diagnostic techniques for surveillance of dysplasia January 27th 2017, 8th Gastro Foundation Weekend for Fellows; Spier Hotel & Conference Centre, Stellenbosch Diagnostic techniques for surveillance of dysplasia Gerhard Rogler, Department of Gastroenterology

More information

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease

More information

Ali Keshavarzian MD Rush University Medical Center

Ali Keshavarzian MD Rush University Medical Center Treatment: Step Up or Top Down? Ali Keshavarzian MD Rush University Medical Center Questions What medication should IBD be treated with? Can we predict which patients with IBD are high risk? Is starting

More information

Extrapolation & Pediatric Development: A case study from pediatric Ulcerative Colitis Richard Strauss, MD

Extrapolation & Pediatric Development: A case study from pediatric Ulcerative Colitis Richard Strauss, MD Extrapolation & Pediatric Development: A case study from pediatric Ulcerative Colitis Richard Strauss, MD Immunology Clinical Development Janssen Research and Development Agenda Rationale for extrapolation

More information

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Journal of Crohn's and Colitis (2012) 6, 991 1030 Available online at www.sciencedirect.com SPECIAL ARTICLE Second European evidence-based consensus on the diagnosis and management of ulcerative colitis

More information

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall

More information

Inflammatory Bowel Disease: Clinical updates. Dr Jeff Chao Princess Alexandra Hospital

Inflammatory Bowel Disease: Clinical updates. Dr Jeff Chao Princess Alexandra Hospital Inflammatory Bowel Disease: Clinical updates Dr Jeff Chao Princess Alexandra Hospital Inflammatory bowel disease 2017 Clinical updates and future directions Pathogenesis Treatment targets Therapeutic agents

More information

Ulcerative colitis (UC) is a. The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers

Ulcerative colitis (UC) is a. The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers James Gregor, MD, Division of Gastroenterology, The University of Western Ontario, London,

More information

Dr Adele Melton Gastroenterologist MBChB (Otago), FRACP

Dr Adele Melton Gastroenterologist MBChB (Otago), FRACP Dr Adele Melton Gastroenterologist MBChB (Otago), FRACP (1) Case presentation CMV in IBD (2) Prevalence (3) Treatment (4) Recommendations / Guidelines (5) Questions 60 year old male Background: UC, pancolitis

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 3 October 2012 REMICADE 100 mg, powder for concentrate for solution for infusion B/1 vial (CIP code: 562 070-1) Applicant:

More information

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Clinical Trials in IBD Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Objectives Today s discussion will address the following topics: Similarities and differences between Crohn

More information

Lifting the lid on a difficile problem part 2 (Clinical) Evidence Based Practice. Problem in evolution (1) Problem in evolution (1) Interventions (2)

Lifting the lid on a difficile problem part 2 (Clinical) Evidence Based Practice. Problem in evolution (1) Problem in evolution (1) Interventions (2) Lifting the lid on a difficile problem part (Clinical) Dr Philip T Mannion Consultant Microbiologist, Rhyl Evidence Based Practice Antibiotic prescribing guidance Isolation policy Hand hygiene (soap and

More information

Case Discussion. Nutrition in IBD. Rémy Meier MD. Ulcerative colitis. Crohn s disease

Case Discussion. Nutrition in IBD. Rémy Meier MD. Ulcerative colitis. Crohn s disease 26.08.2017 Case Discussion Nutrition in IBD Crohn s disease Ulcerative colitis Rémy Meier MD Case Presentation 30 years old female, with diarrhea for 3 months Shool frequency 3-4 loose stools/day with

More information

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health The Role of Surgery in Inflammatory Bowel Disease Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health THANKS FOR INVITING ME! I have no financial disclosures Outline - Who am I and what do I do? -

More information

Pediatric Gastroenterology Referral Guidelines

Pediatric Gastroenterology Referral Guidelines Suggested Pre-Referral Workup This is a general suggestion of possible testing to confirm a suspected diagnosis. Although referrals will be accepted without the suggested work up being complete, to ensure

More information

FOR UK NURSING MEDIA Embargoed until: 00:01 GMT, Friday 13 March 2015

FOR UK NURSING MEDIA Embargoed until: 00:01 GMT, Friday 13 March 2015 Contact: Ross Selby Takeda UK Ltd Email ross.selby@takeda.com News Release FOR UK NURSING MEDIA Embargoed until: 00:01 GMT, Friday 13 March 2015 World s first gut-selective treatment for ulcerative colitis

More information

Exclusive Elemental Nutrition-Children s Perceptions Siobhain Kiernan RGN, RCN, RNP, Msc in Nursing

Exclusive Elemental Nutrition-Children s Perceptions Siobhain Kiernan RGN, RCN, RNP, Msc in Nursing Exclusive Elemental Nutrition-Children s Perceptions Siobhain Kiernan RGN, RCN, RNP, Msc in Nursing Paediatric Inflammatory Bowel Disease (PIBD): PIBD is an umbrella term for two conditions: Crohn s disease

More information

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Version: 6 Date: 2 nd March 2010 Authors: Responsible committee or Director: Review date: Target audience: Stakeholders/

More information

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

My Child Has Inflammatory Bowel Disease : Why? What now? What s next? My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology

More information

Guideline scope Diverticular disease: diagnosis and management

Guideline scope Diverticular disease: diagnosis and management NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Diverticular disease: diagnosis and management The Department of Health in England has asked NICE to develop a clinical guideline on diverticular

More information

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10 Current Management of IBD: From Conventional Agents to Biologics Stephen B. Hanauer, M.D. University of Chicago Treatment Goals Induce and maintain response/ remission Prevent complications Improve quality

More information

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice Ambulatory Emergency Care Pathways Painless Obstructive Jaundice Effective Date: December 2011 Content Summary Ref Title Description 1 Condition Details Identifies pathway details and clinical sign-off

More information

Children who are neutropenic and unwell, even if normothermic, should be assumed to have infection and be treated appropriately.

Children who are neutropenic and unwell, even if normothermic, should be assumed to have infection and be treated appropriately. PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic

More information

IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD

IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD IBD Updates Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida Themes in IBD 213 First-line treatment in IBD New tools for therapeutic monitoring Biologic therapy for CD and

More information